Antipsychotics/Antidepressants/Antiseizure Flashcards
Celexa
Citalopram
SSRI
MOA - block the reuptake of serotonin back into the presynaptic neuron
ADR - hypokalemia, hypomagnesemia, bradycardia, QTc elongation can lead to Torsades de pointe, risk of GI bleeding, sexual dysfunction
Lexapro
Escitalopram
SSRI
MOA - block the reuptake of serotonin back into the presynaptic neuron
ADR - diarrhea, nausea, QTc prolongation (less), risk of GI bleeding, sexual dysfunction
Prozac
Fluoxetine
SSRI
MOA - block the reuptake of serotonin back into the presynaptic neuron
ADR - most activating/insomnia, hypoglycemia, very long half-life, risk of GI bleeding, sexual dysfunction
Zoloft
Sertraline
SSRI
MOA - block the reuptake of serotonin back into the presynaptic neuron
ADR - Activating/insomnia, hypoglycemia, WORST GI PROBLEMS (nausea, diarrhea, vomiting), risk of GI bleeding, sexual dysfunction
Paxil
Paroxetine
SSRI
MOA - block the reuptake of serotonin back into the presynaptic neuron
ADR - MOST SEDATING, MOST ANTI-ACH EFFECTS (SPSS), sexual dysfunction, risk of GI bleeding, QTc prolongation
Cymbalta
Duloxetine
SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - activation, nausea, headache (take at night), dry mouth, sexual dysfunction, avoid in hepatic dysfunction
Effexor
Venlafaxine
SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - hypertension, headache (take at night), nausea, activation, dizziness, sexual dysfunction, dry mouth
Pristiq
Desvenlafaxine
SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - nausea, headache (take at night), dry mouth, dizziness, activation
Elavil
Amitriptyline
TCA - the “original” SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - anti-ACh (SPSS), sedation, sexual dysfunction, weight gain, seizures, QTc prolongation, hypotension
Sinequan
Doxepin
TCA - the “original” SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - anti-ACh (SPSS), sedation, sexual dysfunction, weight gain, seizures, QTc prolongation, hypotension
Pamelol
Nortriptyline
TCA - the “original” SNRI
MOA - block the reuptake of serotonin and norepinephrine back into the presynaptic neuron
ADR - anti-ACh (SPSS), sedation, sexual dysfunction, weight gain, seizures, QTc prolongation, hypotension
Wellbutrin/Zyban
Bupropion
Antidepressant
MOA - norepinephrine-dopamine reuptake inhibitor
ADR - activation, headache (take at night), dry mouth, hypertension, risk of seizures
Remeron
Mirtazapine
Antidepressant
MOA - alpha2-adrenergic antagonist effects stimulate NE and serotonin release, potent antagonist of serotonin and histamine receptors
ADR - sedation, increased appetite, dry mouth
Abilify
Aripiprazole
2nd Generation Antipsychotic
MOA - Dopamine 2 partial agonist
ADR - activating/agitating, akathisia, dyslipidemia, elevation of fasting triglycerides, insulin resistance, FDA warning for impulse-control issues
Zyprexa
Olanzapine
2nd Generation Antipsychotic
MOA - combination of DA and serotonin type 2 receptor site antagonism
ADR - WEIGHT GAIN, GREATEST METABOLIC RISK, orthostatic hypotension, hypertriglyceridemia, hypercholesterolemia
Seroquel
Quetiapine
2nd Generation Antipsychotic
MOA - antagonizes serotonin 5-HT1A and 5-HT2, dopamine D1 and D2, histamine H1, and adrenergic α1 and α2 receptors.
ADR - weight gain, SEDATION, dyslipidemia, insulin resistance, orthostatic hypotension, anti-ACh effects (SPSS)
Risperdal
Risperidone
2nd Generation Antipsychotic
MOA - potent serotonin-5-HT2 antagonist with weaker dopamine-D2 antagonism. Whereas typical antipsychotics are dopamine antagonists, the additional serotonin antagonism increases efficacy for negative symptoms of schizophrenia and reduces the likelihood of extrapyramidal symptoms
ADR - sexual dysfunction, weight gain, dyslipidemia, sedation, hyperprolactinemia (breast enlargement/tenderness), amenorrhea (abnormal absence of menstruation)
Eskalith/Lithobid
Lithium - TWF
Bipolar Disorder Agent/Mood stabilizer
MOA - not known but may work by: 1) inhibiting 2nd messenger enzymes 2) modulating G-proteins 3) interacting with various sites on downstream signal cascade
ADR - nausea (early on), dry mouth, polyuria, tremor, weight gain, hypothyroidism, acne, thinning hair, seizures, delirium, confusion
Nardil
Phenelzine
MAO-I
MOA - inhibit monoamine oxide that breaks down monoamines (DA, NE, serotonin)
ADR - postural hypotension, anti-ACh, SEDATION, sexual dysfunction, hepatic issues, DRUG-DRUG INTERACTIONS (DM-cough suppressant, ALL ANTIDEPRESSANTS, methadone, tramadol, fentanyl, cocaine, amphetamine), DRUG-FOOD INTERACTIONS (cheese, chocolate, beer, wine, smoked meats, pickled or canned foods)
Parnate
Tranylcypromine
MAO-I
MOA - inhibit monoamine oxide that breaks down monoamines (DA, NE, serotonin)
ADR - postural hypotension, anti-ACh, SEDATION, sexual dysfunction, hepatic issues, DRUG-DRUG INTERACTIONS (DM-cough suppressant, ALL ANTIDEPRESSANTS, methadone, tramadol, fentanyl, cocaine, amphetamine), DRUG-FOOD INTERACTIONS (cheese, chocolate, beer, wine, smoked meats, pickled or canned foods)
Thorazine
Chlorpromazine
1st Generation Antipsychotic
MOA - DA2 receptor antagonist, depresses release of hypothalamic and hypophyseal hormones
ADR - akathisia, dystonia, tardive dyskinesia, sedation, anti-ACh effects (SPSS), weight gain, sexual dysfunction
Haldol
Haloperidol
1st Generation Antipsychotic
MOA - DA 1 and 2 receptor antagonist, depresses release of hypothalamic and hypophyseal hormones
ADR - akathisia, dystonia, tardive dyskinesia, sedation, anti-ACh effects (SPSS), weight gain, sexual dysfunction
Prolixin
Fluphenazine
1st Generation Antipsychotic
MOA - DA 1 and 2 receptor antagonist, depresses release of hypothalamic and hypophyseal hormones
ADR - akathisia, dystonia, tardive dyskinesia, sedation, anti-ACh effects (SPSS), weight gain, sexual dysfunction
Clozaril
Clozapine
2nd Generation Antipsychotic
MOA - noradrenolytic, anti-ACh, anti-Histaminic and arousal reaction inhibiting effects are significant, affinity for DA4 receptor accounts for striking effects in control of behavioral and psychiatric symptoms with low incidence of EPS;—-; effective for reducing suicidality
ADR - metabolic side effects, severe sialorrhea (hyper salivation), dose related risk of seizures (>600mg/day), Absolute Neutrophil Count (ANC) every week CBC for first 6 months, every 2 weeks CBC for second 6 months, then monthly CBC thereafter